2018-2023 Global Fludeoxyglucose (18F) Radionuclide Injection Consumption Market Report

August 2018 | 131 pages | ID: 2EFB1EE3528EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Fludeoxyglucose (18F) Radionuclide Injection market for 2018-2023.

Fludeoxyglucose (18F) radionuclide injection is radioactive substance used for diagnostic purpose with Positron Emission Tomography (PET).
Advancement in radiopharmaceutical technologies along with more improve hardware and software of PET imaging are the primary factors driving the growth of Fludeoxyglucose (18F) Radionuclide Injection market.
United States is expected to dominate the global Fludeoxyglucose (18F) Radionuclide Injection market due to high healthcare infrastructure.
ter United States, Fludeoxyglucose (18F) Radionuclide Injection market is then followed by Europe and Asia-Pacific. Europe market is expected to grow due to rise in the number of manufacturing companies of Fludeoxyglucose (18F) Radionuclide Injection. In Asia-Pacific, India and China are expected to be major market owing to increasing geriatric population and cancer incidences.
Over the next five years, LPI(LP Information) projects that Fludeoxyglucose (18F) Radionuclide Injection will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Fludeoxyglucose (18F) Radionuclide Injection market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Cancer
• Coronary Artery Disease
• Others

Segmentation by application:

• Hospitals
• Clinics
• Diagnostics Center

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• Zevacor Pharma
• Queen's PET Imaging
• Triad Isotopes
• NCM USA Bronx
• Spectron MRC
• Petnet Solutions
• Shertech Laboratories
• Precision Nuclear

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Fludeoxyglucose (18F) Radionuclide Injection consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Fludeoxyglucose (18F) Radionuclide Injection market by identifying its various subsegments.
• Focuses on the key global Fludeoxyglucose (18F) Radionuclide Injection manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Fludeoxyglucose (18F) Radionuclide Injection with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Fludeoxyglucose (18F) Radionuclide Injection submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Fludeoxyglucose (18F) Radionuclide Injection Consumption 2013-2023
  2.1.2 Fludeoxyglucose (18F) Radionuclide Injection Consumption CAGR by Region
2.2 Fludeoxyglucose (18F) Radionuclide Injection Segment by Type
  2.2.1 Cancer
  2.2.2 Coronary Artery Disease
  2.2.3 Others
2.3 Fludeoxyglucose (18F) Radionuclide Injection Consumption by Type
  2.3.1 Global Fludeoxyglucose (18F) Radionuclide Injection Consumption Market Share by Type (2013-2018)
  2.3.2 Global Fludeoxyglucose (18F) Radionuclide Injection Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Fludeoxyglucose (18F) Radionuclide Injection Sale Price by Type (2013-2018)
2.4 Fludeoxyglucose (18F) Radionuclide Injection Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
  2.4.3 Diagnostics Center
2.5 Fludeoxyglucose (18F) Radionuclide Injection Consumption by Application
  2.5.1 Global Fludeoxyglucose (18F) Radionuclide Injection Consumption Market Share by Application (2013-2018)
  2.5.2 Global Fludeoxyglucose (18F) Radionuclide Injection Value and Market Share by Application (2013-2018)
  2.5.3 Global Fludeoxyglucose (18F) Radionuclide Injection Sale Price by Application (2013-2018)

3 GLOBAL FLUDEOXYGLUCOSE (18F) RADIONUCLIDE INJECTION BY PLAYERS

3.1 Global Fludeoxyglucose (18F) Radionuclide Injection Sales Market Share by Players
  3.1.1 Global Fludeoxyglucose (18F) Radionuclide Injection Sales by Players (2016-2018)
  3.1.2 Global Fludeoxyglucose (18F) Radionuclide Injection Sales Market Share by Players (2016-2018)
3.2 Global Fludeoxyglucose (18F) Radionuclide Injection Revenue Market Share by Players
  3.2.1 Global Fludeoxyglucose (18F) Radionuclide Injection Revenue by Players (2016-2018)
  3.2.2 Global Fludeoxyglucose (18F) Radionuclide Injection Revenue Market Share by Players (2016-2018)
3.3 Global Fludeoxyglucose (18F) Radionuclide Injection Sale Price by Players
3.4 Global Fludeoxyglucose (18F) Radionuclide Injection Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Fludeoxyglucose (18F) Radionuclide Injection Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Fludeoxyglucose (18F) Radionuclide Injection Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 FLUDEOXYGLUCOSE (18F) RADIONUCLIDE INJECTION BY REGIONS

4.1 Fludeoxyglucose (18F) Radionuclide Injection by Regions
  4.1.1 Global Fludeoxyglucose (18F) Radionuclide Injection Consumption by Regions
  4.1.2 Global Fludeoxyglucose (18F) Radionuclide Injection Value by Regions
4.2 Americas Fludeoxyglucose (18F) Radionuclide Injection Consumption Growth
4.3 APAC Fludeoxyglucose (18F) Radionuclide Injection Consumption Growth
4.4 Europe Fludeoxyglucose (18F) Radionuclide Injection Consumption Growth
4.5 Middle East & Africa Fludeoxyglucose (18F) Radionuclide Injection Consumption Growth

5 AMERICAS

5.1 Americas Fludeoxyglucose (18F) Radionuclide Injection Consumption by Countries
  5.1.1 Americas Fludeoxyglucose (18F) Radionuclide Injection Consumption by Countries (2013-2018)
  5.1.2 Americas Fludeoxyglucose (18F) Radionuclide Injection Value by Countries (2013-2018)
5.2 Americas Fludeoxyglucose (18F) Radionuclide Injection Consumption by Type
5.3 Americas Fludeoxyglucose (18F) Radionuclide Injection Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Fludeoxyglucose (18F) Radionuclide Injection Consumption by Countries
  6.1.1 APAC Fludeoxyglucose (18F) Radionuclide Injection Consumption by Countries (2013-2018)
  6.1.2 APAC Fludeoxyglucose (18F) Radionuclide Injection Value by Countries (2013-2018)
6.2 APAC Fludeoxyglucose (18F) Radionuclide Injection Consumption by Type
6.3 APAC Fludeoxyglucose (18F) Radionuclide Injection Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Fludeoxyglucose (18F) Radionuclide Injection by Countries
  7.1.1 Europe Fludeoxyglucose (18F) Radionuclide Injection Consumption by Countries (2013-2018)
  7.1.2 Europe Fludeoxyglucose (18F) Radionuclide Injection Value by Countries (2013-2018)
7.2 Europe Fludeoxyglucose (18F) Radionuclide Injection Consumption by Type
7.3 Europe Fludeoxyglucose (18F) Radionuclide Injection Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Fludeoxyglucose (18F) Radionuclide Injection by Countries
  8.1.1 Middle East & Africa Fludeoxyglucose (18F) Radionuclide Injection Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Fludeoxyglucose (18F) Radionuclide Injection Value by Countries (2013-2018)
8.2 Middle East & Africa Fludeoxyglucose (18F) Radionuclide Injection Consumption by Type
8.3 Middle East & Africa Fludeoxyglucose (18F) Radionuclide Injection Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Fludeoxyglucose (18F) Radionuclide Injection Distributors
10.3 Fludeoxyglucose (18F) Radionuclide Injection Customer

11 GLOBAL FLUDEOXYGLUCOSE (18F) RADIONUCLIDE INJECTION MARKET FORECAST

11.1 Global Fludeoxyglucose (18F) Radionuclide Injection Consumption Forecast (2018-2023)
11.2 Global Fludeoxyglucose (18F) Radionuclide Injection Forecast by Regions
  11.2.1 Global Fludeoxyglucose (18F) Radionuclide Injection Forecast by Regions (2018-2023)
  11.2.2 Global Fludeoxyglucose (18F) Radionuclide Injection Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Fludeoxyglucose (18F) Radionuclide Injection Forecast by Type
11.8 Global Fludeoxyglucose (18F) Radionuclide Injection Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Zevacor Pharma
  12.1.1 Company Details
  12.1.2 Fludeoxyglucose (18F) Radionuclide Injection Product Offered
  12.1.3 Zevacor Pharma Fludeoxyglucose (18F) Radionuclide Injection Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Zevacor Pharma News
12.2 Queen's PET Imaging
  12.2.1 Company Details
  12.2.2 Fludeoxyglucose (18F) Radionuclide Injection Product Offered
  12.2.3 Queen's PET Imaging Fludeoxyglucose (18F) Radionuclide Injection Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Queen's PET Imaging News
12.3 Triad Isotopes
  12.3.1 Company Details
  12.3.2 Fludeoxyglucose (18F) Radionuclide Injection Product Offered
  12.3.3 Triad Isotopes Fludeoxyglucose (18F) Radionuclide Injection Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Triad Isotopes News
12.4 NCM USA Bronx
  12.4.1 Company Details
  12.4.2 Fludeoxyglucose (18F) Radionuclide Injection Product Offered
  12.4.3 NCM USA Bronx Fludeoxyglucose (18F) Radionuclide Injection Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 NCM USA Bronx News
12.5 Spectron MRC
  12.5.1 Company Details
  12.5.2 Fludeoxyglucose (18F) Radionuclide Injection Product Offered
  12.5.3 Spectron MRC Fludeoxyglucose (18F) Radionuclide Injection Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Spectron MRC News
12.6 Petnet Solutions
  12.6.1 Company Details
  12.6.2 Fludeoxyglucose (18F) Radionuclide Injection Product Offered
  12.6.3 Petnet Solutions Fludeoxyglucose (18F) Radionuclide Injection Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Petnet Solutions News
12.7 Shertech Laboratories
  12.7.1 Company Details
  12.7.2 Fludeoxyglucose (18F) Radionuclide Injection Product Offered
  12.7.3 Shertech Laboratories Fludeoxyglucose (18F) Radionuclide Injection Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Shertech Laboratories News
12.8 Precision Nuclear
  12.8.1 Company Details
  12.8.2 Fludeoxyglucose (18F) Radionuclide Injection Product Offered
  12.8.3 Precision Nuclear Fludeoxyglucose (18F) Radionuclide Injection Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Precision Nuclear News

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Fludeoxyglucose (18F) Radionuclide Injection
Table Product Specifications of Fludeoxyglucose (18F) Radionuclide Injection
Figure Fludeoxyglucose (18F) Radionuclide Injection Repo